SecBot SecBot

USAU

U.S. GOLD CORP.
Nasdaq· Metal Mining· Inc. NV· CIK 0000027093 Materials & Mining
$10.66 −0.42 (−3.79%)
Oct 23 4:00 PM ET · prev $11.08
Market cap
$183.1M
Micro cap
Median target
$27.50
+158% · range $22.00–30.00
1 year
−32.8%
from $15.87 · Oct 27
30 days
−28.0%
from $14.80
52-week range
$10.66–22.60
at the low
Avg volume 20D
166.5K
shares / day
Short interest
🔒 Subscribers only
Insider net
+$158.3K
3 buyers · 0 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
8
analyzed by SecBot
SecBot read BEARISH 2 reports · 90 days
Balance 1 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 2/2
Strongest BEARISH U.S. Gold Corp.'s S-3 shelf registration (File No. 333-298504) became effective on September 1, 2026. This…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    3 insiders bought $158.3K at an average $14.65. No open-market sales. Price is 27% below their cost.

  • InstitutionsBULLISH

    Q2 2026: 17 added (0 new), 7 trimmed or exited.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.235 → −$0.420 over 90 days. 1 up, 0 down in 30 days.

  • TrendDOWNTREND

    27% below its 50-day average. New closing low $10.66 on Oct 23.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
MACKENZIE FINANCIAL CORPADD506,414$7.8M
MILLENNIUM MANAGEMENT LLCTRIM98,726$1.5M
VANGUARD PORTFOLIO MANAGEMENT LLCTRIM98,440$1.5M
SUSQUEHANNA INTERNATIONAL GROUP, LLPADD95,983$1.5M
Nuveen, LLCDOUBLED48,589$744.9K
GOLDMAN SACHS GROUP INCTRIM34,790$533.3K
SIMPLEX TRADING, LLCDOUBLED27,710$424.8K
CITADEL ADVISORS LLCTRIM20,932$320.9K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Apr 2026
12-month targets · 3 analysts

Price is below the lowest target. Median implies +158%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
Apr 2, 2026HC Wainwright & Co.
REITERATE
REITERATEBuy
Jan 7, 2026HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Dec 15, 2025Roth Capital
REITERATE
REITERATEBuy
Sep 25, 2025HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Sep 22, 2025Roth Capital
MAINTAIN
MAINTAINBuy
Aug 4, 2025Roth Capital
REITERATE
REITERATEBuy

Insider ledger

Form 4
$158.3K
bought · 3 insiders
$0
sold · 0 insiders
−27.3%
vs their $14.65 cost
DateInsiderTypeValue
Sep 28, 2026
Waldkirch Michael N
Director
AWARD8,324 sh
Sep 28, 2026
NORMAN LUKE ANTHONY
Director
AWARD11,271 sh
Sep 28, 2026
NORMAN LUKE ANTHONY
Director
AWARD19,589 sh
Sep 28, 2026
FIPKE JOHANNA
Director
AWARD8,324 sh
Sep 28, 2026
Waldkirch Michael N
Director
AWARD4,789 sh
Sep 28, 2026
Schafer Robert W
Director
AWARD4,789 sh
Sep 28, 2026
FIPKE JOHANNA
Director
AWARD4,789 sh
Sep 28, 2026
Francis Kevin A.
VP-Exploration
AWARD6,310 sh

Earnings setup

Estimates
−$0.42
EPS estimate, this quarter
−79%
estimate change, 90 days
1↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.42-$0.42–-$0.42-78.7%$0.00
Next Q-$0.19-$0.19–-$0.19+17.4%$0.00
Current FY-$0.94-$1.07–-$0.81-13.6%$0.00
Next FY-$0.92-$0.92–-$0.92—$0.00

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 28, 2026 Insider
Waldkirch Michael N was granted 8,324 shares
Director
Sep 28, 2026 Insider
NORMAN LUKE ANTHONY was granted 11,271 shares
Director
Sep 28, 2026 Insider
NORMAN LUKE ANTHONY was granted 19,589 shares
Director
Sep 14, 2026 Earnings calendar
USAU Q1 2027 Earnings Scheduled — 2026-09-14
Sep 2, 2026 SEC
U.S. Gold Corp.'s S-3 shelf registration (File No. 333-298504) became effective on September 1, 2026. This allows the…
EFFECT — Impact 5/10
Aug 27, 2026 SEC
U.S. Gold Corp. filed a DEFA14A providing notice of its 2026 Annual Meeting of Stockholders to be held virtually on…
DEFA14A — Impact 2/10
Jul 31, 2026 Event
Duavee
WARNING: ENDOMETRIAL CANCER, CARDIOVASCULAR DISORDERS, AND PROBABLE DEMENTIA • Women taking DUAVEE s
Jun 30, 2026 Inst.
MACKENZIE FINANCIAL CORP — ADD
506,414 shares ($7.8M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Sep 14, 2026
Earnings date
USAU Q1 2027 Earnings Scheduled — 2026-09-14
Sep 8, 2026
Press release
U.S. Gold Corp. Announces Participation in September 2026 Investor Conferences
CHEYENNE, Wyo., Sept. 8, 2026 /PRNewswire/ -- U.S. Gold Corp. ("U.S. Gold," the "Company," "we," "our" or "us") (Nasdaq: USAU), a U.S. focused gold…
Aug 27, 2026
Press release
U.S. Gold Corp. to Present at Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference
Chairman, Mr. Luke Norman to Present at 11:05 a.m. Eastern Time on September 9th, 2026 CHEYENNE, Wyo., Aug. 27, 2026 /PRNewswire/ -- U.S. Gold Corp…
Aug 20, 2026
Press release
U.S. Gold Corp. Provides CEO Update - August 2026
Advancing the Fully Permitted, Shovel Ready CK Gold Project CHEYENNE, Wyo., Aug. 20, 2026 /PRNewswire/ -- U.S. Gold Corp. ("U.S. Gold," the…
Jul 31, 2026
FDA
Duavee
WARNING: ENDOMETRIAL CANCER, CARDIOVASCULAR DISORDERS, AND PROBABLE DEMENTIA • Women taking DUAVEE should not take additional estrogens [see Warnings

SecBot reports

8 filings · 2 bullish · 1 bearish · 5 neutral
All USAU filing & press-release reports (8)